Hadassah

Hadassah Genetic Discovery Article Singled Out for Recognition

Monday, Feb 8 2016

The January 2015 article which describes the Hadassah Medical Center’s discovery and cure of a rare genetic blood disease which appeared in Blood, the journal of the American Society of Hematology, has been chosen by the journal as one of ten outstanding publications for 2015.

The articles are selected based on the quality of the work, interest to the field of hematology, the number of citations, and how often the paper was accessed.

In this Hadassah article entitled “Early-Onset Evans Syndrome, Immunodeficiency and Premature Immunosenescence Associated with Tripeptidyl-Peptidase II Deficiency,” Dr. Paulina Stepensky, Bone Marrow Specialist and Senior Physician in Hemato-Oncology, along with her colleagues at Hadassah and in Germany, describe a potentially fatal protein deficiency which leads to immune system problems and a variable propensity toward viral infection.

As they reveal, it is the deficiency of this TPP2 molecule that leads T and B immune system cells to deteriorate prematurely (immunosenescence) and for the patient’s immune system to attack itself (autoimmunity). As the authors state, “TPP2 deficiency is the first primary immunodeficiency linking premature immunosenescence to severe autoimmunity.”

The medical scenario began when Hadassah’s physicians encountered the case of a 21-month-old Palestinian boy with early-onset Evans syndrome (autoimmune anemia), viral infections, and progressive leukopenia (reduction in white blood cells). An older sibling, a girl, had been followed in another hospital from the age of 18 months when she presented with white blood cell loss and anemia. She was treated with intravenous immunoglobulin and steroids, but became increasingly unresponsive to therapy at the age of 33 months. At 37 months, she passed away.

Through gene sequencing, Dr. Stepensky, along with Prof. Orly Elpeleg, head of Hadassah’s Department of Genetic and Metabolic Diseases, identified the damaged gene that led to the TPP2 deficiency. With the help of German researchers, the physicians were able to characterize the mechanism of the disease and the way TPP2 is involved in the proper functioning of the immune system. As Dr. Stepensky explains, “We actually discovered a new mechanism of the immune system, a previously unknown path that leads to premature aging of the immune system, which both allows us to diagnose this disease and will also help us better understand the whole system.”

The boy underwent a stem cell transplant at Hadassah, with donor cells from a healthy sibling. In October 2014, six months after the transplant, his physicians reported that “the child remains well with no infectious, autoimmune or lymphoproliferative manifestations. He is no longer prescribed any immunosuppressive medication. Thus, at this early time point, the clinical features that led to the decision to transplant have resolved.”

The physicians conclude that “the determination of senescent T and B cells should be part of the diagnostic evaluation of any child with refractory multilineage cytopenias (reduction in blood cells).”

Comments

No comments yet.
First Name
Email
Comment
Enter this word:

Related Stories

alt_text

Wednesday, Aug 15 2018

Hadassah Hospital’s Bone Marrow Transplant Department Receives International Acclaim

In a first for Israel, Hadassah Medical Organization’s Bone Marrow Transplantation and Cancer Immunotherapy Department has recently received full accreditation by the Joint Accreditation Committee ISCT-EUROPE & EBMT (JACIE), Europe’s only official accreditation body in the field.

READ MORE ›
alt_text

Tuesday, Aug 14 2018

Hadassah Hospital Helps Educate Mikvah Attendants To Bolster Women’s Health

After a woman emerges from the ritual bath (mikveh) and wraps herself in a towel, says mikveh attendant Daniella Salomon, “I keep an eye out” for anything unusual.

READ MORE ›
alt_text

Tuesday, Aug 7 2018

American Medical Attaché and Consulate Nurse Tour Hadassah Hospital Ein Kerem

Jennifer Kmiecinski, Medical Attaché to the Consulate General of the United States in Israel, visited Hadassah Hospital Ein Kerem earlier this month to assess the level of health care available to American personnel serving in Israel.

READ MORE ›
alt_text

Thursday, Aug 2 2018

Two Hadassah Ophthalmology Articles Are Among Top 100 Most Cited in Four Decades

Two articles by Hadassah Medical Organization ophthalmologists are among the 100 most cited ophthalmology articles from 1975-2017. One is ranked 11th.

READ MORE ›

Donation Questions

donorservices@hadassah.org

(800) 928-0685

Membership Questions

membership@hadassah.org

(800) 664-5646

Missions Department

missions@hadassah.org

(800) 237-1517

Contact Us

40 Wall Street

New York, NY 10005

support@hadassah.org

More ›

Show More